Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1401 | 8069 | 35.3 | 74% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
14 | 4 | ORTHOPEDICS//DENTISTRY, ORAL SURGERY & MEDICINE//SPORT SCIENCES | 808941 |
32 | 3 | OSTEOPOROSIS//VITAMIN D//OSTEOPOROSIS INTERNATIONAL | 107093 |
1401 | 2 | BISPHOSPHONATES//ZOLEDRONIC ACID//BONE METASTASES | 8069 |
1643 | 1 | BONE METASTASES//SKELETAL RELATED EVENTS//BONE METASTASIS | 2558 |
2746 | 1 | BISPHOSPHONATES//ZOLEDRONIC ACID//ALENDRONATE | 2159 |
7693 | 1 | OSTEONECROSIS OF THE JAW//OSTEONECROSIS//BRONJ | 1339 |
9580 | 1 | BONE PAIN PALLIATION//STRONTIUM 89//PAIN PALLIATION | 1141 |
21017 | 1 | CLEANROOM WIPERS//URA 1430 CNRS//CONTAMINAT CONTROL | 437 |
26214 | 1 | BONE TARGETING//OSTEOTROPIC DRUG DELIVERY SYSTEM//ACIDIC OLIGOPEPTIDE | 260 |
30034 | 1 | ALENDRONATE SODIUM//BISPHOSPHONATE DRUG//3 AMINO 1 HYDROXYPROPYLIDENE 1 | 175 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BISPHOSPHONATES | authKW | 3211326 | 25% | 42% | 2026 |
2 | ZOLEDRONIC ACID | authKW | 1366648 | 8% | 60% | 606 |
3 | BONE METASTASES | authKW | 1110841 | 8% | 44% | 671 |
4 | OSTEONECROSIS OF THE JAW | authKW | 702269 | 3% | 89% | 208 |
5 | SKELETAL RELATED EVENTS | authKW | 564993 | 2% | 85% | 175 |
6 | BONE METASTASIS | authKW | 470766 | 5% | 30% | 422 |
7 | OSTEONECROSIS | authKW | 360467 | 4% | 26% | 362 |
8 | BRONJ | authKW | 307042 | 1% | 96% | 85 |
9 | DENOSUMAB | authKW | 289307 | 3% | 38% | 202 |
10 | PAMIDRONATE | authKW | 286042 | 2% | 40% | 191 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 19660 | 27% | 0% | 2153 |
2 | Dentistry, Oral Surgery & Medicine | 12993 | 10% | 0% | 844 |
3 | Radiology, Nuclear Medicine & Medical Imaging | 2969 | 9% | 0% | 693 |
4 | Endocrinology & Metabolism | 2525 | 8% | 0% | 644 |
5 | Chemistry, Inorganic & Nuclear | 1490 | 6% | 0% | 473 |
6 | Pharmacology & Pharmacy | 1071 | 9% | 0% | 752 |
7 | Urology & Nephrology | 920 | 4% | 0% | 312 |
8 | Orthopedics | 451 | 3% | 0% | 215 |
9 | Nuclear Science & Technology | 386 | 3% | 0% | 227 |
10 | Materials Science, Biomaterials | 378 | 1% | 0% | 112 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | UNIT CLIN ONCOL | 108821 | 1% | 34% | 84 |
2 | WESTON PK HOSP | 45765 | 0% | 34% | 36 |
3 | ORAL MAXILLO IAL SURG | 29573 | 6% | 2% | 457 |
4 | BONE MUSCULOSKELETAL PROGRAMME | 23236 | 0% | 36% | 17 |
5 | CHIM STRUCT BIOMOL | 22449 | 0% | 42% | 14 |
6 | PHYSIOPATHOL ORPT OSSEUSE THER IE TUMEU | 21251 | 0% | 24% | 23 |
7 | UMYMFOR CONICET FCEYN | 19140 | 0% | 56% | 9 |
8 | CLIN ENDOCRINOL BONE DIS | 13505 | 0% | 71% | 5 |
9 | SUPPORT CARE CLIN | 12348 | 0% | 47% | 7 |
10 | ENDOCRINOL BREAST CANC | 12102 | 0% | 80% | 4 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF BONE ONCOLOGY | 54965 | 0% | 36% | 40 |
2 | BONE | 20499 | 2% | 3% | 191 |
3 | CLINICAL & EXPERIMENTAL METASTASIS | 7654 | 1% | 3% | 64 |
4 | JOURNAL OF BONE AND MINERAL RESEARCH | 7340 | 1% | 2% | 115 |
5 | JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY | 7250 | 2% | 1% | 138 |
6 | ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY | 5512 | 1% | 3% | 45 |
7 | SUPPORTIVE CARE IN CANCER | 4975 | 1% | 2% | 76 |
8 | NUCLEAR MEDICINE AND BIOLOGY | 4916 | 1% | 2% | 70 |
9 | CALCIFIED TISSUE INTERNATIONAL | 4516 | 1% | 2% | 77 |
10 | CANCER TREATMENT REVIEWS | 4401 | 1% | 2% | 48 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BISPHOSPHONATES | 3211326 | 25% | 42% | 2026 | Search BISPHOSPHONATES | Search BISPHOSPHONATES |
2 | ZOLEDRONIC ACID | 1366648 | 8% | 60% | 606 | Search ZOLEDRONIC+ACID | Search ZOLEDRONIC+ACID |
3 | BONE METASTASES | 1110841 | 8% | 44% | 671 | Search BONE+METASTASES | Search BONE+METASTASES |
4 | OSTEONECROSIS OF THE JAW | 702269 | 3% | 89% | 208 | Search OSTEONECROSIS+OF+THE+JAW | Search OSTEONECROSIS+OF+THE+JAW |
5 | SKELETAL RELATED EVENTS | 564993 | 2% | 85% | 175 | Search SKELETAL+RELATED+EVENTS | Search SKELETAL+RELATED+EVENTS |
6 | BONE METASTASIS | 470766 | 5% | 30% | 422 | Search BONE+METASTASIS | Search BONE+METASTASIS |
7 | OSTEONECROSIS | 360467 | 4% | 26% | 362 | Search OSTEONECROSIS | Search OSTEONECROSIS |
8 | BRONJ | 307042 | 1% | 96% | 85 | Search BRONJ | Search BRONJ |
9 | DENOSUMAB | 289307 | 3% | 38% | 202 | Search DENOSUMAB | Search DENOSUMAB |
10 | PAMIDRONATE | 286042 | 2% | 40% | 191 | Search PAMIDRONATE | Search PAMIDRONATE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KHAN, AA , MORRISON, A , HANLEY, DA , FELSENBERG, D , MCCAULEY, LK , O'RYAN, F , REID, IR , RUGGIERO, SL , TAGUCHI, A , TETRADIS, S , ET AL (2015) DIAGNOSIS AND MANAGEMENT OF OSTEONECROSIS OF THE JAW: A SYSTEMATIC REVIEW AND INTERNATIONAL CONSENSUS.JOURNAL OF BONE AND MINERAL RESEARCH. VOL. 30. ISSUE 1. P. 3 -23 | 232 | 87% | 74 |
2 | RUGGIERO, SL , DODSON, TB , FANTASIA, J , GOODDAY, R , AGHALOO, T , MEHROTRA, B , O'RYAN, F , (2014) AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS POSITION PAPER ON MEDICATION-RELATED OSTEONECROSIS OF THE JAW-2014 UPDATE.JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY. VOL. 72. ISSUE 10. P. 1938 -1956 | 142 | 92% | 173 |
3 | FLIEFEL, R , TROLTZSCH, M , KUHNISCH, J , EHRENFELD, M , OTTO, S , (2015) TREATMENT STRATEGIES AND OUTCOMES OF BISPHOSPHONATE-RELATED OSTEONECROSIS OF THE JAW (BRONJ) WITH CHARACTERIZATION OF PATIENTS: A SYSTEMATIC REVIEW.INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY. VOL. 44. ISSUE 5. P. 568 -585 | 163 | 85% | 21 |
4 | KUHL, S , WALTER, C , ACHAM, S , PFEFFER, R , LAMBRECHT, JT , (2012) BISPHOSPHONATE-RELATED OSTEONECROSIS OF THE JAWS - A REVIEW.ORAL ONCOLOGY. VOL. 48. ISSUE 10. P. 938 -947 | 145 | 96% | 48 |
5 | FORD, J , CUMMINS, E , SHARMA, P , ELDERS, A , STEWART, F , JOHNSTON, R , ROYLE, P , JONES, R , MULATERO, C , TODD, R , ET AL (2013) SYSTEMATIC REVIEW OF THE CLINICAL EFFECTIVENESS AND COST-EFFECTIVENESS, AND ECONOMIC EVALUATION, OF DENOSUMAB FOR THE TREATMENT OF BONE METASTASES FROM SOLID TUMOURS.HEALTH TECHNOLOGY ASSESSMENT. VOL. 17. ISSUE 29. P. 1 -+ | 130 | 89% | 19 |
6 | CAMPISI, G , FEDELE, S , FUSCO, V , PIZZO, G , DI FEDE, O , BEDOGNI, A , (2014) EPIDEMIOLOGY, CLINICAL MANIFESTATIONS, RISK REDUCTION AND TREATMENT STRATEGIES OF JAW OSTEONECROSIS IN CANCER PATIENTS EXPOSED TO ANTIRESORPTIVE AGENTS.FUTURE ONCOLOGY. VOL. 10. ISSUE 2. P. 257 -275 | 124 | 92% | 11 |
7 | LANGE, R , TER HEINE, R , KNAPP, R , DE KLERK, JMH , BLOEMENDAL, HJ , HENDRIKSE, NH , (2016) PHARMACEUTICAL AND CLINICAL DEVELOPMENT OF PHOSPHONATE-BASED RADIOPHARMACEUTICALS FOR THE TARGETED TREATMENT OF BONE METASTASES.BONE. VOL. 91. ISSUE . P. 159 -179 | 123 | 88% | 0 |
8 | LAM, MGEH , DE KLERK, JMH , VAN RIJK, PP , ZONNENBERG, BA , (2007) BONE SEEKING RADIOPHARMACEUTICALS FOR PALLIATION OF PAIN IN CANCER PATIENTS WITH OSSEOUS METASTASES.ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. VOL. 7. ISSUE 4. P. 381 -397 | 124 | 91% | 30 |
9 | ABRAHAMSSON, PA , BODY, JJ , COLEMAN, RE , COLOMER, R , COSTA, L , CRINO, L , DIRIX, L , GNANT, M , GRALOW, J , HADJI, P , ET AL (2008) GUIDANCE ON THE USE OF BISPHOSPHONATES IN SOLID TUMOURS: RECOMMENDATIONS OF AN INTERNATIONAL EXPERT PANEL.ANNALS OF ONCOLOGY. VOL. 19. ISSUE 3. P. 420 -432 | 88 | 78% | 251 |
10 | TOLIA, M , ZYGOGIANNI, A , KOUVARIS, JR , MERISTOUDIS, C , MARGARI, N , KARAKITSOS, P , KOKAKIS, I , KARDAMAKIS, D , PAPADIMITRIOU, C , MYSTAKIDOU, K , ET AL (2014) THE KEY ROLE OF BISPHOSPHONATES IN THE SUPPORTIVE CARE OF CANCER PATIENTS.ANTICANCER RESEARCH. VOL. 34. ISSUE 1A. P. 23 -37 | 112 | 73% | 10 |
Classes with closest relation at Level 2 |